Key result
COVID-19 pathophysiology and the factors defining clinical progress are discussed without specific quantitative findings in this abstract.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grant Waterer (2021) studied this question. COVID-19 pathophysiology and the factors defining clinical progress are discussed without specific quantitative findings in this abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: